RNU6-479P

Across TCGA pan-cancer cohorts, RNU6-479P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-479P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-479P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-479P is over-expressed in tumor.

KIRC and KICH are the cancer types where RNU6-479P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-479P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.144	.023	2	view →
KICH	Male	II,III,IV	+0.231	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU6-479P–KIRC

Open the KIRC breakdown →